Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

NCT04880395 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

265

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Intervention Arm: dolutegravir/lamivudine
DRUG: Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)

Sponsor

Fundación Huésped

Collaborators

[object Object]
[object Object]